This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: University of Ghent. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Nick Jacobs - Innovator in Therapeutic Compounds
Introduction
Nick Jacobs is a prominent inventor based in Ghent, Belgium. He has made significant contributions to the field of therapeutic compounds, particularly in the treatment of diseases influenced by microtubule stability. His innovative work has the potential to impact the medical community positively.
Latest Patents
Nick Jacobs holds a patent for Peloruside analogs. This invention provides new therapeutic compounds aimed at treating diseases caused or influenced by microtubule stability, such as proliferative diseases. The compounds are phenyl-analogs of the naturally occurring peloruside. Notably, these analogs are easier to synthesize, which opens up the possibility of producing them in large quantities for therapeutic use. He has 1 patent to his name.
Career Highlights
Nick Jacobs is affiliated with the University of Ghent, where he continues to advance his research and innovation in therapeutic compounds. His work is characterized by a commitment to improving treatment options for various diseases.
Collaborations
Some of his notable coworkers include Dries Van Den Bossche and Gert Smans. Their collaboration enhances the research environment and fosters innovation in their respective fields.
Conclusion
Nick Jacobs is a dedicated inventor whose work in therapeutic compounds demonstrates the potential for significant advancements in medical treatments. His contributions are paving the way for new possibilities in healthcare.